150211413FJB
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/FJB865. NCPD/ILNA credit will be available until May 25, 2027. “Off-the-Shelf” Choices in RRMM: Oncology Nurse Guidance on Delivering Quality Care With BCMA and Non-BCMA Immunotherapy In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported by an independent medical education grant from GSK. Disclosure information is available at the beginning of the video presentation.

Management of Common Infections in the Outpatient Setting.

Modern Interventions in Neuroendocrine Carcinoma: DLL3-Directed BiTE Therapy in Community Settings

Top 10 Mistakes That Get Residency Programs Cited By ACGME & How To Avoid Them

Watch Drs. Saad & Barata on prostate cancer updates at #AUA26: https://bit.ly/Prostate26DC-Y

DeLIVERing Prevention Podcast: Optimizing Uptake of Hepatitis A and B Vaccination

Advancing Talent Systems in Education & Social Impact Pt. 2

Expanding Bispecific Options for Acute Lymphoblastic Leukemia

Updated Thyroid Cancer Guidelines: Personalized Approaches for Optimized Care

🩺 2024 Medical Terminology Made Easy - Part 1

Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC

Sarah Paine - Why Putin and Xi can't escape geography

Can You Pass These 25 NCLEX Cardiac Questions?

Pathway to Precision in Ovarian Cancer

Sleep Wake Disorders

Ironing Out the Challenges of PV Targeting the Hepcidin Pathway

HNSCC: Current and Emerging Therapeutic Strategies

Early Defense: Answering Key Questions About RSV Prevention in Infants

Targeting With Precision in Advanced Ovarian Cancer

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma

